Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2021 17:37 ET | Source: Evaxion Biotech

Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities

COPENHAGEN, Denmark, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (the “Company” or “Evaxion”), a clinical-stage biotechnology company specializing in the development of AI-driven...
December 23, 2020 01:30 ET | Source: Evaxion Biotech

Evaxion Biotech Doses First Patient in Phase I/IIa Melanoma Trial of Cancer Vaccine EVX-02 in Combination With Checkpoint Inhibitors

COPENHAGEN, Denmark, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company developing AI-driven immunotherapies, announces today the dosing of the first patient...
December 17, 2020 01:30 ET | Source: Evaxion Biotech

Evaxion Biotech Appoints Marianne Søgaard as Chairwoman

COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer...
December 09, 2020 06:00 ET | Source: Evaxion Biotech

EU Boosts Evaxion’s Artificial Intelligence Vaccine Research

EIB signs €20 million (DKK 149 million) loan agreement with Danish research and development company Evaxion Biotech A/S.Evaxion will use financing for research and development into its proprietary...
December 09, 2020 05:00 ET | Source: Evaxion Biotech

Evaxion Biotech Announces Publication in Nature Communications Describing Improved Selection of Immunotherapy Targets

COPENHAGEN, Denmark, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage AI-immunology company developing immunotherapies to improve the lives of patients with cancer and...
October 01, 2020 07:00 ET | Source: Evaxion Biotech

Evaxion Biotech Launches New AI Powered Platform, RAVEN, to Enable Faster Response to Emerging Viral Pandemics

COPENHAGEN, Denmark, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies and vaccines, announces...
June 30, 2020 09:51 ET | Source: Evaxion Biotech

Evaxion Biotech Appoints Chair and Strengthens Board of Directors

Appoints Kim Bjoernstrup as Chair, deeply experienced industry executiveAppoints Helen M. Boudreau to Board of Directors, veteran CFO and biopharma executive COPENHAGEN, Denmark, June 30, 2020 ...
October 30, 2019 08:00 ET | Source: Evaxion Biotech

Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak as Chief Financial Officer and Further Strengthens Senior Executive Team

COPENHAGEN, Denmark, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of...